CN Patent

CN101965347B — 作为激酶抑制剂的吡唑并吡啶

Assigned to Array Biopharma Inc · Expires 2013-01-02 · 13y expired

What this patent protects

式I的化合物可用于抑制CHK1和/或CHK2。公开了使用式I的化合物以及其立体异构体和药学上可接受的盐来体外、原位和体内诊断、预防或治疗哺乳动物细胞中的这样的病症或相关联的病理状况的方法。

USPTO Abstract

式I的化合物可用于抑制CHK1和/或CHK2。公开了使用式I的化合物以及其立体异构体和药学上可接受的盐来体外、原位和体内诊断、预防或治疗哺乳动物细胞中的这样的病症或相关联的病理状况的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101965347B
Jurisdiction
CN
Classification
—
Expires
2013-01-02
Drug substance claim
No
Drug product claim
No
Assignee
Array Biopharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.